Back to Search
MATTHEW RANSON, M.D.
M.D.
Interventional Pain Medicine Physician
NPI: 1679797278IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pain Medicine (Anesthesiology) Physician
Anesthesiology — Pain Medicine
Code: 207LP2900X
46448(AZ)
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
46448(AZ)
Education
WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Class of 2003
Research & Publications (20)
Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.
PMID 19332730·J Clin Oncol·2009
3-trial
Sonographic depiction of posttraumatic alveolar-interstitial disease: the hand-held diagnosis of a pulmonary contusion.
PMID 18815577·J Trauma·2009
8-other
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.
PMID 19628770·Am J Pathol·2009
8-other
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.
PMID 19367282·Br J Cancer·2009
3-trial
Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008.
PMID 19442041·Anticancer Agents Med Chem·2009
6-review
The CD-loop of PAI-2 (SERPINB2) is redundant in the targeting, inhibition and clearance of cell surface uPA activity.
PMID 19442270·BMC Biotechnol·2009
8-other
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
PMID 19367283·Br J Cancer·2009
4-observational
Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.
PMID 19237630·J Clin Oncol·2009
3-trial
Conformational rearrangements of plasminogen activator inhibitor type 2.
PMID 19401808·Cell Mol Life Sci·2009
8-other
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
PMID 19606016·Anticancer Drugs·2009
4-observational
Revisiting the biological roles of PAI2 (SERPINB2) in cancer.
PMID 18548086·Nat Rev Cancer·2008
6-review
Optimisation of circulating biomarkers of cell death for routine clinical use.
PMID 18304966·Ann Oncol·2008
4-observational
Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.
PMID 18837931·Ann N Y Acad Sci·2008
8-other
Use of near-infrared spectroscopy as a physiologic monitor for intra-abdominal hypertension.
PMID 18469636·J Trauma·2008
3-trial
DNA methylation in circulating tumour DNA as a biomarker for cancer.
PMID 19662228·Biomark Insights·2008
8-other
Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation.
PMID 18511548·FASEB J·2008
8-other
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer.
PMID 18475294·Br J Cancer·2008
3-trial
Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
PMID 18690354·Thromb Haemost·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4838 E BASELINE RD STE 108
MESA, AZ 85206 - Phone
- (480) 724-7091
Quick Facts
- NPI
- 1679797278
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile